Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children
Jeffrey S. Hyams(Connecticut Children's Medical Center), Robert N. Baldassano(Children's Hospital of Philadelphia), George D. Ferry(Baylor College of Medicine), G. Veereman‐Wauters(Semmelweis University), Anne M. Griffiths(University of Toronto), Stanley A. Cohen(Troy Gastroenterology), Harland S. Winter(Massachusetts General Hospital), Grace Liu, James Markowitz(Philadelphia University), Allan Olson, Suzanne Travers, Wallace Crandall, Subra Kugathasan(Children's Healthcare of Atlanta), Jewel Johanns(Janssen (United States)), Robert Heuschkel(European CanCer Organisation)
Cited by 872
Related Papers
Human gut microbiome viewed across age and geography
|Nature|2012|7.9k
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
|Science|2011|6.6k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k